WallStSmart

BRBI BR Partners S.A. ADSs (BRBI)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates -18837% more annual revenue ($2.17T vs $-11.57B). NMR leads profitability with a 16.7% profit margin vs 0.0%. NMR trades at a lower P/E of 11.8x. NMR earns a higher WallStSmart Score of 70/100 (B-).

BRBI

Buy

50

out of 100

Grade: C-

Growth: 6.0Profit: 6.5Value: 5.3Quality: 4.0
Piotroski: 3/9

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BRBI3 strengths · Avg: 9.0/10
Operating MarginProfitability
32.5%10/10

Strong operational efficiency at 32.5%

Return on EquityProfitability
22.1%9/10

Every $100 of equity generates 22 in profit

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

NMR4 strengths · Avg: 9.0/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

Areas to Watch

BRBI4 concerns · Avg: 3.3/10
P/E RatioValuation
28.6x4/10

Moderate valuation

Market CapQuality
$322.60M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : BRBI

The strongest argument for BRBI centers on Operating Margin, Return on Equity, Price/Book.

Bull Case : NMR

The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bear Case : BRBI

The primary concerns for BRBI are P/E Ratio, Market Cap, Profit Margin.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Key Dynamics to Monitor

BRBI profiles as a value stock while NMR is a growth play — different risk/reward profiles.

NMR carries more volatility with a beta of 0.61 — expect wider price swings.

NMR is growing revenue faster at 27.5% — sustainability is the question.

BRBI generates stronger free cash flow (-13M), providing more financial flexibility.

Bottom Line

NMR scores higher overall (70/100 vs 50/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BRBI BR Partners S.A. ADSs

FINANCIAL SERVICES · CAPITAL MARKETS · USA

BRBI BR Partners S.A., is an investment bank that specializes in providing financial services for entrepreneurs and families in Brazil. The company is headquartered in So Paulo, Brazil.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?